Verification evidence is still being completed.
PDF / print export
Antegenes
Tartu, Estonia
- Verified lead
- Peeter Padrik, MD, PhD
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Founder and Chief Executive Officer
- 2026 technical specialization
- Polygenic Risk Testing, Cancer Prevention Diagnostics, and Medical Genetics Services
- Review cycle
- May 2026
- Full address
- Raatuse 21, 50603 Tartu, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Antegenes team page confirming the current executive lead in Tartu.
- Editorial note
- Antegenes is published as an Estonia diagnostics node because its official team and contact pages clearly confirm the founder-CEO, licensed Tartu healthcare footprint, and ISO 13485 / CE-marked testing posture.
Polygenic Risk Testing, Cancer Prevention Diagnostics, and Medical Genetics Services
CE-marked IVD tests, ISO 13485:2016 quality management system, Estonian Health Board healthcare-provider licences
Antegenes is published as an Estonia diagnostics node because its official team and contact pages clearly confirm the founder-CEO, licensed Tartu healthcare footprint, and ISO 13485 / CE-marked testing posture.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Tartu, Estonia
Antegenes
Polygenic Risk Testing, Cancer Prevention Diagnostics, and Medical Genetics Services · Clinical genetics and prevention-diagnostics platform
Antegenes runs polygenic risk testing, cancer prevention diagnostics, and medical genetics services in Tartu, Estonia.
- Lead
- Peeter Padrik, MD, PhD (verified ↗)
- Address
- Raatuse 21, 50603 Tartu, Estonia (source ↗)
- Compliance
- CE-marked IVD tests · ISO 13485:2016 quality management system
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical genetics and prevention-diagnostics platform
- Capabilities
- Polygenic Risk Testing · Cancer Prevention Diagnostics · Medical Genetics Services
- Founded
- 2018
- Headcount
- 11-50
Clinical profileSTATUS: VERIFIED MARCH 2026
Peeter Padrik, MD, PhD
Founder and Chief Executive Officer
Full addressRaatuse 21, 50603 Tartu, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Antegenes contact page listing the Tartu operating address and registration details.
Open sourceClinical genetics and prevention-diagnostics platform
Tartu, Estonia. Polygenic Risk Testing, Cancer Prevention Diagnostics, and Medical Genetics Services. Review completed on 21 Mar 2026.
Estonian Health Board and EU IVD quality oversight
CE-marked IVD tests, ISO 13485:2016 quality management system, Estonian Health Board healthcare-provider licences
Polygenic Risk Testing, Cancer Prevention Diagnostics, and Medical Genetics Services
Antegenes is published as an Estonia diagnostics node because its official team and contact pages clearly confirm the founder-CEO, licensed Tartu healthcare footprint, and ISO 13485 / CE-marked testing posture.
Editorial note
Antegenes is published as an Estonia diagnostics node because its official team and contact pages clearly confirm the founder-CEO, licensed Tartu healthcare footprint, and ISO 13485 / CE-marked testing posture.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Polygenic Risk Testing
Cancer Prevention Diagnostics
Medical Genetics Services
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Genetic testing laboratory services
Clinical genetics support systems
Quality-managed IVD workflow
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Antegenes located?
- Antegenes operates from Raatuse 21, 50603 Tartu, Estonia, Tartu, Estonia.
- Who runs Antegenes?
- Antegenes is led by Peeter Padrik, MD, PhD, Founder and Chief Executive Officer. Verified 21 Mar 2026.
- What certifications does Antegenes hold?
- Antegenes is documented under CE-marked IVD tests, ISO 13485:2016 quality management system.
- What does Antegenes do?
- Antegenes runs polygenic risk testing, cancer prevention diagnostics, and medical genetics services in Tartu, Estonia. Core capabilities: Polygenic Risk Testing, Cancer Prevention Diagnostics, Medical Genetics Services.
Editorial context
Related technical briefs
Briefs that name Tartu as a covered market or city.